RB1 and neoplasm: Finally, we demonstrated the ability to identify RB1 promoter DNA hypermethylation, a known cause of sporadic, non-heritable RB, as well as DNA methylation profiles that may predict an aggressive tumor subtype less likely to respond to medical therapy.